Potential and future strategies for radiotherapy in hepatocellular carcinoma

Liver International

Volumn 29, Issue 2, 2009, Pages 145-146

  Aebersold, Daniel M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SORAFENIB;

ADVANCED CANCER; CANCER CONTROL; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; EDITORIAL; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TOXICITY; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; RADIOFREQUENCY ABLATION; RADIOSENSITIVITY; SOCIAL SUPPORT; STRATEGIC PLANNING; TREATMENT RESPONSE; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; HUMANS; RADIOTHERAPY;

EID: 58149506227     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01899.x     Document Type: Editorial

References (10)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
3. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-42.
4. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-71.
5. Dawson LA. The evolving role of radiation therapy in hepatocellular carcinoma. Cancer Radiother 2008; 12: 96-101.
6. Seong J, Lee IJ, Shim SJ, et al. A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea. Liver Int 2009; 29: 147-52.
7. Seong J, Park HC, Han KH, et al. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003; 55: 329-36.
8. Ben-Josef E, Normolle D, Ensminger WD, et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005; 23: 8739-47.
9. Mornex F, Girard N, Beziat C, et al. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French Phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006; 66: 1152-8.
10. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-90.